For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with ...

Some 20% to 30% of gout patients also have CKD, the researchers said, which is not surprising since they share many risk ...

Researchers at Ulster University’s Personalised Medicine Centre in Derry have made a significant breakthrough in healthcare ...

For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with ...

The safety of left atrial appendage occlusion (LAAO) device implantation in patients with CKD has been uncertain and tied with complications.

Researchers at Ulster University’s Personalised Medicine Centre in Derry have made a significant breakthrough by developing a ...

Iran: A new study published in the BMC journal Trials is exploring the potential benefits of melatonin supplementation for ...

Denosumab treatment for osteoporosis appears more hazardous in postmenopausal women with advanced chronic kidney disease (CKD).

The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 weeks after administration and ...

While diabetes gets a lot of attention, people with Type 1 Diabetes (T1D) are frequently overlooked when drug companies ...